Discover

DMAA
Drugs Made In America Acquisition Corp.
10.64
5 x 10.62
5 x 10.54
bid
ask
-
0.01
0.09%
5 @ 04:00 PM
10.64 +0.00 (0.00%)
Ytd2.60%
1y4.42%
10.63
day range
10.64
10.17
52 week range
10.65
Open10.63Prev Close10.65Low10.63High10.64Mkt Cap258.31M
Vol100.15KAvg Vol115.39KEPS0.20P/E53.20Forward P/EN/A
BetaN/AShort RatioN/AInst. OwnN/ADividendN/ADiv YieldN/A
Ex Div DateN/AEarning05-2050-d Avg10.60200-d Avg10.441yr Est0.00
Income Statement
Operating Expenses143.30K
Selling, General and Administrative Expense143.30K
Operating Income-143.30K
Net Income1.97M
Net Income Common Stock1.97M
Net Income Common Stock (USD)1.97M
Consolidated Income1.97M
Earnings per Basic Share0.06
Earnings per Basic Share (USD)0.06
Earnings per Diluted Share0.06
Earning Before Interest & Taxes (EBIT)1.97M
Earning Before Interest & Taxes (USD)1.97M
Weighted Average Shares33.72M
Weighted Average Shares Diluted33.72M
Balance Sheet
Cash and Equivalents14.89K
Cash and Equivalents (USD)14.89K
Investments242.02M
Investments Non-Current242.02M
Current Assets14.89K
Total Assets242.04M
Debt Current100.00K
Total Debt100.00K
Current Liabilities492.17K
Total Liabilities7.39M
Accumulated Retained Earnings (Deficit)-7.38M
Shareholders Equity-7.38M
Shareholders Equity (USD)-7.38M
Assets Non-Current242.02M
Total Debt (USD)100.00K
Liabilities Non-Current6.90M
Trade and Non-Trade Payables238.18K
Cash Flow
Net Cash Flow from Financing100.00K
Net Cash Flow / Change in Cash & Cash Equivalents8.75K
Issuance (Repayment) of Debt Securities 100.00K
Net Cash Flow from Operations-91.25K